Project Grant R21NS139341
Award Date
9/17/24
Completion Date
9/16/26
Dollars Obligated
$2K
Funding Federal Agency
Fogarty International Center
Awarding Federal Agency
National Institute of Neurological Disorders and Stroke
Federal Grant Program
93.989
Assistance Type
Project Grant
Place of Performance
Boston, MA 02115, USA
Similar Awards
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $796,500 project grant to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to investigate clonal evolution in Fanconi anemia. The grant period runs from September 30, 2023 to September 29, 2026. As a non-profit pediatric teaching hospital and research center, Boston Children's Hospital will leverage its expertise in pediatric medicine, genomics, and...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $1,416,000 Project Grant to The Children's Hospital Corporation (Boston Children's Hospital), a non-profit teaching hospital and research center affiliated with Harvard Medical School. The grant, titled "IND-ENABLING STUDIES OF POLYMERASE INHIBITORS FOR BMF DUE TO TELOMERE EXHAUSTION", will support a 2-year research project from Sep 1, 2023 to Aug 31, 2025. Through this funding, Boston...
The federal Project Grant award in the amount of $617,367 was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The award is being used by the Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on "BASE EDITING TO IMPROVE CONDITIONING AND TRANSPLANT OF BONE MARROW FAILURE PATIENTS". The research project aims to leverage innovative gene editing techniques to enhance the...
The U.S. Department of the Army Medical Command has awarded a $577,383.00 Project Grant to The Children's Hospital Corporation, doing business as Boston Children's Hospital, under the Military Medical Research and Development (CFDA 12.420) federal grant program. This grant, with a performance period from September 1, 2024 to August 31, 2027, will support the hospital's research to develop base editing techniques to improve conditioning and transplantation of bone marrow failure patients. As a...
This federal Project Grant award from the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development) to The Children's Hospital Corporation, doing business as Boston Children's Hospital, is providing $788,475.00 to enhance the efficacy of botulinum neurotoxin for the treatment of neurogenic bladder. The award period runs from Sep 1, 2023 to Aug 31, 2026. Boston Children's Hospital, a non-profit pediatric teaching hospital and research center affiliated with Harvard Medical...
This is a $1,593,000 federal Project Grant awarded by the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310). The grant was awarded on September 1, 2023 to The Children's Hospital Corporation, doing business as Boston Children's Hospital, a non-profit pediatric teaching hospital and research center. The funding supports a 3-year research project to "DEFINING THE UNIVERSAL GENOMIC LANGUAGE OF HALLMARKS IN TUMOR...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $777,927 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will support research into targeting PARP signaling as a novel treatment for urologic complications of spinal cord injury from August 15, 2023 through August 14, 2026. The Military Medical Research and Development program aims to advance biomedical solutions for battlefield...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $177,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund a project to develop a nanoparticle-based CRISPR screen to identify genetic regulators of chemoresistance. The screen will be used to investigate medical solutions for the battlefield by transforming health care for service members and the public...
The Department of the Army Medical Command awarded a $3,062,579 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Children's Hospital Corporation (Boston Children's Hospital) on April 15, 2025. The grant supports an integrated research approach to identify biopsychosocial aspects of pain in fibrous dysplasia/McCune-Albright syndrome, a rare genetic condition, over a performance period ending on April 14, 2029. Boston Children's Hospital, a...
The Children's Hospital Corporation, doing business as Boston Children's Hospital, was awarded a $796,500 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The grant will fund research from July 2021 through June 2024 to investigate the contribution of rapamycin-insensitive processes to neurological symptoms in tuberous sclerosis complex. The Military Medical Research and Development program aims to advance biomedical...